Photodynamic Therapy with the Silicon Phthalocyanine Pc 4 Induces Apoptosis in Mycosis Fungoides and Sezary Syndrome
Author(s) -
Minh Lam,
Yoojin Lee,
Min Deng,
Andrew H. Hsia,
Kelly A. Morrissey,
Yan Chun-lin,
Kashif Azzizudin,
Nancy L. Oleinick,
Thomas S. McCormick,
Kevin D. Cooper,
Elma D. Baron
Publication year - 2010
Publication title -
advances in hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.371
H-Index - 31
eISSN - 1687-9112
pISSN - 1687-9104
DOI - 10.1155/2010/896161
Subject(s) - mycosis fungoides , photodynamic therapy , cutaneous t cell lymphoma , medicine , lymphoma , photosensitizer , pathology , cancer research , apoptosis , peripheral t cell lymphoma , cutaneous lymphoma , jurkat cells , immunology , t cell , chemistry , immune system , biochemistry , organic chemistry
Our current focus on the effects of Photodynamic Therapy (PDT) using silicon phthalocyanine Pc 4 photosensitizer on malignant T lymphocytes arose due to preclinical observations that Jurkat cells, common surrogate for human T cell lymphoma, were more sensitive to Pc 4-PDT-induced killing than epidermoid carcinoma A431 cells. Mycosis fungoides (MF) as well as Sezary syndrome (SS) are variants of cutaneous T-cell lymphoma (CTCL) in which malignant T-cells invade the epidermis. In this study, we investigated the cytotoxicity of Pc 4-PDT in peripheral blood cells obtained from patients with SS and in skin biopsies of patients with MF. Our data suggest that Pc 4-PDT preferentially induces apoptosis of CD4 + CD7 − malignant T-lymphocytes in the blood relative to CD11b + monocytes and nonmalignant T-cells. In vivo Pc 4-PDT of MF skin also photodamages the antiapoptotic protein Bcl-2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom